Acyclovir and Hydrocortisone
Name: Acyclovir and Hydrocortisone
- Acyclovir and Hydrocortisone drug
- Acyclovir and Hydrocortisone drugs like
- Acyclovir and Hydrocortisone names
- Acyclovir and Hydrocortisone dosage
- Acyclovir and Hydrocortisone standard dose
- Acyclovir and Hydrocortisone therapeutic effect
- Acyclovir and Hydrocortisone adverse effects
What do I need to tell my doctor BEFORE I take Acyclovir and Hydrocortisone?
- If you have an allergy to acyclovir, hydrocortisone, or any other part of acyclovir and hydrocortisone.
- If you are allergic to any drugs like this one, any other drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.
This medicine may interact with other drugs or health problems.
Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this medicine with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.
Excipient information presented when available (limited, particularly for generics); consult specific product labeling.
Xerese: Acyclovir 5% and hydrocortisone 1% (5 g)
Brand Names U.S.
Refer to adult dosing.
Dosing Hepatic Impairment
There are no dosage adjustments provided in the manufacturer’s labeling.
Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin. Avoid combination
Ceritinib: Corticosteroids may enhance the hyperglycemic effect of Ceritinib. Monitor therapy
Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy. Monitor therapy
Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased. Monitor therapy
Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase. Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase. Larger doses of hyaluronidase may be required. Consider therapy modification
Talimogene Laherparepvec: Antiherpetic Antivirals may diminish the therapeutic effect of Talimogene Laherparepvec. Monitor therapy
Concerns related to adverse effects:
• Sensitization: Use has been associated with local sensitization (irritation).
• Herpes labialis: Appropriate use: Treatment should begin with the first signs or symptoms. For external use only to the lips and around the mouth; do not apply to eye, inside the mouth or nose, or on the genitals. Contact healthcare provider if cold sore does not heal in 2 weeks.
Concurrent drug therapy issues:
• Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.
• Immunocompromised patients: Use with caution in immunocompromised patients.
Pregnancy Risk Factor B Pregnancy Considerations
Animal reproduction studies and studies in pregnant women have not been conducted with Xerese. Systemic exposure of acyclovir and hydrocortisone after topical administration is minimal. See individual agents.